Search results
On private call, Democrats weigh 'comatose or dead' Biden and alternatives
Semafor· 3 days agoA ticket with her at the top, combined with someone who balances her brand weaknesses (examples...
Best Steroids For Strength And Size - Top Anabolic Steroid Stack For Strong Muscle Growth And Power
Outlook India· 18 hours agoAnavar (Oxandrolone) is a mild oral steroid that’s well-tolerated, and known for its ability to...
‘Frustrating’ partisan stalemate: the new normal for farm bills?
Missouri Independent· 19 hours agoWASHINGTON — The stalemate over the current farm bill may be solidifying a new era in farm politics...
A ‘scared’ Biden aide sounds an alarm
Semafor· 10 hours agoTop White House economist Jared Bernstein said Biden “makes decisions on everything from student debt relief to 301 tariffs to housing policy” and...
Virat Kohli's Reaction As Fan Climbs On Tree To See T20 World Cup Victory Parade Is All Of Us |...
NDTV· 21 hours agoThere was a party atmosphere in Mumbai as thousands gathered on the streets to witness the Indian...
AMFI releases new stock categorization, cut-offs for largecap hiked to Rs 84,000 crore - The...
The Economic Times· 21 hours agoThe Association of Mutual Funds in India (AMFI) on Thursday has officially released the market cap...
Telecom tariffs are decided by market dynamics, govt clarifies
The Economic Times· 12 hours agoThe Ministry of Communications has clarified that rates of telecommunication services are decided by...
WWE Money in the Bank 2024 Predictions: Damien Priest vs Seth Rollins and Full Match Card
Pinkvilla· 14 hours agoMoney in the Bank 2024 will be the 12th edition of the Money in the Bank series. MITB is one of the
Pressure on diagnostics industry will continue for another five years : A Velumani, Thyrocare Tech
The Economic Times· 20 hours agoMany hospitals took diagnostics as a core business. Just a holistic view coming in because clearly ...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 2 days agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...